Innovus Pharmaceuticals (INNVD) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Tarsus Pharmaceuticals: Undervalued Growth Potential with Strong Sales Performance and Strategic Market ExpansionNovember 14, 2024 | markets.businessinsider.comCorvus Pharmaceuticals’ Soquelitinib: Optimism and Market Potential Drive Buy RatingNovember 14, 2024 | markets.businessinsider.comCorvus Unveils Data On Ciforadenant's Potential To Overcome Immunotherapy Resistance In MCRPCNovember 11, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV) and Acumen Pharmaceuticals (ABOS)October 8, 2024 | markets.businessinsider.comThe Analyst Verdict: Inovio Pharmaceuticals In The Eyes Of 4 ExpertsOctober 4, 2024 | benzinga.comINmune Bio: NK Cell Therapy INKmune For mCRPC Is Another Shot On GoalSeptember 30, 2024 | seekingalpha.comNivagen Pharmaceuticals Sells MedisourceRx Business Unit to Leading Health & Wellness CompanySeptember 24, 2024 | businesswire.comApellis Pharmaceuticals Inc.September 22, 2024 | wsj.comRXRX Recursion Pharmaceuticals, Inc.August 14, 2024 | seekingalpha.comInovio Pharmaceuticals, Inc. (INO) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comInovio Pharmaceuticals Inc. stock rises Wednesday, still underperforms marketAugust 1, 2024 | marketwatch.comTRACON Pharmaceuticals Inc.May 18, 2024 | wsj.comAldevron Announces Strategic Partnership with Acuitas TherapeuticsMay 13, 2024 | businesswire.comIdentiv, Inc. (NASDAQ:INVE) Q1 2024 Earnings Call TranscriptMay 9, 2024 | msn.comInovio Pharmaceuticals: Neutral On INO-3107 Amidst Stock Dilution And High ValuationApril 24, 2024 | seekingalpha.comInovio Pharmaceuticals Stock Is Diving Today: What's Happening?April 16, 2024 | msn.comSyros Pharmaceuticals, Inc. Common Stock (SYRS)April 11, 2024 | nasdaq.comVertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion DealApril 10, 2024 | msn.comSupernus Pharmaceuticals Shares Slip 6.9% After FDA Says Drug Application Not ReadyApril 8, 2024 | marketwatch.comStocks to Watch: Intel, Vanda Pharmaceuticals, OneMedNetApril 4, 2024 | marketwatch.comHow Much Does It Cost To Make Novo Nordisk's Ozempic? Shockingly Low Against $1,000 Price Tag, Study ShowsMarch 28, 2024 | msn.comELDN Eledon Pharmaceuticals, Inc.March 28, 2024 | seekingalpha.comSanders calls for Novo Nordisk to slash Ozempic, Wegovy pricesMarch 27, 2024 | msn.comBuy Rating Affirmed for Esperion on Growth Potential Post-FDA ApprovalMarch 25, 2024 | markets.businessinsider.comNovo Nordisk targets heart disease in $1.1 billion dealMarch 25, 2024 | msn.comINO Stock Earnings: Inovio Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023March 6, 2024 | markets.businessinsider.comAmpio Pharmaceuticals Up 26% on Securities-Sale UpdatesFebruary 28, 2024 | marketwatch.comThe Analyst Verdict: Regeneron Pharmaceuticals In The Eyes Of 10 ExpertsFebruary 27, 2024 | markets.businessinsider.comiBio stock jumps on sale of preclinical PD-1 agonist antibody programFebruary 26, 2024 | msn.comIovance rallies nearly 40% on FDA approval, stock offeringFebruary 20, 2024 | msn.comWexford pharmaceutical company expands antiviral initiativesFebruary 9, 2024 | bizjournals.comNovo Nordisk Has a Weight-Loss Pill But Can’t Make It YetFebruary 9, 2024 | msn.comCitius Pharmaceuticals Inc (CTXR)February 8, 2024 | investing.comInnovAge Holding Corp. (NASDAQ:INNV) Q2 2024 Earnings Call TranscriptFebruary 7, 2024 | insidermonkey.comApellis Pharmaceuticals Inc (APLS)February 5, 2024 | investing.comNovo Nordisk Spends $11 Billion on Meeting Obesity Drug DemandFebruary 5, 2024 | msn.comTRACON Pharmaceuticals Inc (TCON)February 2, 2024 | uk.investing.comNovo Nordisk Earnings: High Expectations as the Firm Sprints Ahead In PharmaceuticalsJanuary 29, 2024 | morningstar.comSyros Pharmaceuticals Inc (SYRS)January 23, 2024 | investing.comCold Relief Roll-On Market Projected to Surge at 8.7% CAGR, Reaching US$926.7 Million by 2030, Persistence Market ResearchJanuary 22, 2024 | finance.yahoo.comARS Pharmaceuticals Inc SPRYJanuary 21, 2024 | morningstar.comMove Over, Novo Nordisk -- This Is the Pharmaceutical Company I am Most Bullish On in 2024January 14, 2024 | nasdaq.comCold Relief Roll On Market Set for Remarkable Growth: Expected Valuation of US$ 1,156.5 Million by 2033, CAGR at 8.3% | Future Market Insights, Inc.December 6, 2023 | finance.yahoo.comPromising Biomarker Data and Optimal Dose Selection Drive Buy Rating for Acumen PharmaceuticalsNovember 14, 2023 | markets.businessinsider.comImpel Pharmaceuticals Inc IMPLNovember 4, 2023 | morningstar.comTelcon RF Pharmaceutical Inc.November 2, 2023 | wsj.comLipella Pharmaceuticals closes on $2 million private placement offeringOctober 27, 2023 | bizjournals.comAnalysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Maravai Lifesciences Holdings (MRVI)September 27, 2023 | markets.businessinsider.comNovartis names new board member after international boss steps downSeptember 6, 2023 | reuters.comWhere Olema Pharmaceuticals Stands With AnalystsSeptember 5, 2023 | markets.businessinsider.com Get Innovus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INNVD and its competitors with MarketBeat's FREE daily newsletter. Email Address INNVD Media Mentions By Week INNVD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INNVD News Sentiment▼0.000.97▲Average Medical News Sentiment INNVD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INNVD Articles This Week▼00▲INNVD Articles Average Week Get Innovus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INNVD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MRKR News Today DARE News Today TRAW News Today NRXP News Today EQ News Today LPCN News Today IGC News Today CMMB News Today SLGL News Today CVKD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:INNVD) was last updated on 1/10/2025 by MarketBeat.com Staff From Our PartnersHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredShocker: Trump’s 1st Day Could Change EverythingA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredLIMITED TIME OFFER — Weiss’ gold playbookIt's critical you get all the critical facts BEFORE the Gold Bull Market Summit recording goes offline. Do ...Weiss Ratings | SponsoredKamala’s final humiliation These ten investments legendary financial analyst Porter Stansberry is exposing after he spent time at Mar-a-L...Porter & Company | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovus Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
